PRECLINICAL MECHANISTIC AND CLINICAL EVALUATION OF THE CORTICOSTEROID DEXAMETHASONE'S DETRIMENTAL EFFECTS ON IMMUNE CHECKPOINT BLOCKADE IN GLIOBLASTOMA CANCER

被引：0

作者：

Iorgulescu, Bryan ^{[1
]}

Gokhale, Prafulla ^{[1
]}

Speranza, Maria ^{[1
]}

Eschle, Benjamin ^{[1
]}

Poitras, Michael ^{[1
]}

Wilkens, Margaret ^{[1
]}

Soroko, Kara ^{[1
]}

Chhoeu, Chhayheng ^{[1
]}

Knott, Aine ^{[1
]}

Gao, Yan ^{[1
]}

Lim-Fat, Mary Jane ^{[1
]}

Baker, Gregory ^{[2
]}

Bonal, Dennis ^{[1
]}

Quang-De Nguyen ^{[1
]}

Grant, Gareth ^{[1
]}

Ligon, Keith

Sorger, Peter ^{[2
]}

Chiocca, E. ^{[3
]}

Anderson, Ana ^{[3
]}

Kirschmeier, Paul ^{[1
]}

Sharpe, Arlene ^{[2
]}

Freeman, Gordon ^{[1
]}

Reardon, David ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Harvard Med Sch, Boston, MA 02115 USA

[3] BWH, Boston, MA USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷

关键词：

D O I：

10.1136/jitc-2020-SITC2020.0209

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

209

引用

页码：A123 / A126

页数：4

共 50 条

[21] Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy
Adachi, Keishi
Tamada, Koji
[J]. CANCER SCIENCE, 2015, 106 (08) : 945 - 950
[22] Smac mimetics synergistically improve the efficacy of cancer immunotherapies including immune checkpoint blockade in preclinical models
LaCasse, Eric
Beug, Shawn
Healey, Cristin
Beauregard, Caroline
Sanda, Tarun
Alain, Tommy
Korneluk, Robert
[J]. CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
[23] Mutations Associated with No Durable Clinical Benefit to Immune Checkpoint Blockade in Non-S-Cell Lung Cancer
Zhu, Guangsheng
Ren, Dian
Lei, Xi
Shi, Ruifeng
Zhu, Shuai
Zhou, Ning
Zu, Lingling
De Mello, Ramon Andrade
Chen, Jun
XU, Song
[J]. CANCERS, 2021, 13 (06) : 1 - 12
[24] Meta-analysis of preclinical measures of efficacy in immune checkpoint blockade therapies and comparison to clinical efficacy estimates
Juan Miguel Tenorio-Pedraza
Jörg Lippert
Rolf Burghaus
Christian Scheerans
[J]. Translational Medicine Communications, 8 (1)
[25] IDO-BASED IMMUNE CHECKPOINT BLOCKADE FOR PEDIATRIC BRAIN TUMORS: PRECLINICAL DATA AND CLINICAL TRIAL DESIGN
Johnson, Theodore
Li, Minghui
Gamble, Denise
Macdonald, Tobey
Munn, David
[J]. PEDIATRIC BLOOD & CANCER, 2015, 62 : 104 - 104
[26] Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma
Garg, Abhishek D.
Vandenberk, Lien
Van Woensel, Matthias
Belmans, Jochen
Schaaf, Marco
Boon, Louis
De Vleeschouwer, Steven
Agostinis, Patrizia
[J]. ONCOIMMUNOLOGY, 2017, 6 (04):
[27] Effects of prophylactic high and low doses of corticosteroid on the efficacy of immune checkpoint blockade in murine hepatocellular carcinoma models.
Shen, Ying-Chun
Yeh, Ching-Ping
Jin, Lu
Chang, Nai-Wen
Hsu, Chia-Lang
Ou, Da-Liang
Chu, Ching-Liang
Cheng, Ann-Lii
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[28] Repurposing tin mesoporphyrin as a novel immune checkpoint therapy in the treatment of cancer: A preclinical evaluation.
Arnold, James N.
Muliaditan, Tamara
Opzoomer, James W.
Caron, Jonathan
Okesola, Mary
Kosti, Paris
Lall, Sharanpreet
Van Hemelrijck, Mieke
Dazzi, Francesco
Tutt, Andrew
Grigoriadis, Anita
Gillett, Cheryl
Madden, Stephen F.
Burchell, Joy M.
Kordasti, Shahram
Diebold, Sandra S.
Spicer, James F.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[29] Immune checkpoint blockade for locally advanced or recurrent/metastatic cervical cancer: An update on clinical data
Song, Zhuo
Zou, Kun
Zou, Lijuan
[J]. FRONTIERS IN ONCOLOGY, 2022, 12
[30] Immune checkpoint blockade and biomarkers of clinical response in non-small cell lung cancer
Hallqvist, Andreas
Rohlin, Anna
Raghavan, Sukanya
[J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2020, 92 (06)

← 1 2 3 4 5 →